Metoclopramide

Reglan Lawsuits Continue to Drive Debate Over Corporate Immunity, Generic Preemption

Edward F. Blizzard | Posted 05.25.2011

Read More: Corporate Immunity, Food & Drug Administration, Preemption, Metoclopramide, Reglan, Fda, Business News
Edward F. Blizzard

The Supreme Court is currently awaiting word from the Obama administration regarding its position on generic drug manufacturers' claims that federal regulation of prescription drugs grants them immunity from lawsuits in state courts.

Read Post

The Generic Problem with Health Care Reform

Edward F. Blizzard | Posted 11.17.2011

Read More: Generic Drugs, Healthcare, Tardive Dyskinesia, Metoclopramide, Reglan, Healthy Living News
Edward F. Blizzard

While making prescription medications more affordable for every American is a laudable goal, increasing the availability of these drugs raises serious concerns.

Read Post

Studies Show Popular Reflux Drug Reglan Dangerous, Ineffective

Edward F. Blizzard | Posted 11.17.2011

Read More: Gastroesophageal Reflux, Metoclopramide, Fda, GERD, Gastroparesis, Tardive Dyskinesia, Reglan, Healthy Living News
Edward F. Blizzard

Last year, the Food & Drug Administration issued a black box warning, the strongest of its kind, for the drug Reglan and its generic forms metoclopram...

Read Post

Reglan Lawsuits Spark Debate Over Generic Preemption, Corporate Immunity

Edward F. Blizzard | Posted 11.17.2011

Read More: Supreme Court, Preemption, Metoclopramide, Obama Administration, Wyeth, Generic Drugs, Reglan, Healthy Living News
Edward F. Blizzard

The U.S. Supreme Court asked the Obama administration this week for its position on an appeal filed by generic drug manufacturers who argue that feder...

Read Post